MYCIO Wealth Partners’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-558
Closed -$39K 505
2016
Q3
$39K Sell
558
-335
-38% -$24.4K 0.01% 385
2016
Q2
$66K Buy
893
+86
+11% +$5.94K 0.01% 300
2016
Q1
$52K Sell
807
-45
-5% -$3.06K 0.01% 320
2015
Q4
$66K Buy
852
+26
+3% +$2.06K 0.01% 259
2015
Q3
$68K Buy
826
+45
+6% +$4K 0.01% 260
2015
Q2
$69K Buy
781
+558
+250% +$51.2K 0.01% 261
2015
Q1
$20K Buy
+223
New +$19.8K ﹤0.01% 406

Other funds holding NVS

MYCIO Wealth Partners's NVS Position: Q4 2016 in Review

MYCIO Wealth Partners sold out of Novartis (NVS) in Q4 2016, closing a stake of 558 shares — an estimated $39K sold.

MYCIO Wealth Partners first reported a position in NVS in Q1 2015 and held it in 7 quarters. The position peaked at $69K in Q2 2015. 905 funds tracked by Wall St. Rank hold NVS as of Q4 2016.

  • MYCIO Wealth Partners reported no remaining Novartis position as of Q4 2016 after selling out during the quarter.
  • MYCIO Wealth Partners sold 558 Novartis shares in Q4 2016, an estimated $39K.
  • MYCIO Wealth Partners first reported a position in Novartis in Q1 2015 and held it in 7 quarters.
  • MYCIO Wealth Partners's Novartis position peaked at $69K in Q2 2015.
  • 905 funds tracked by Wall St. Rank held Novartis as of Q4 2016.

Based on MYCIO Wealth Partners's 13F filing for Q4 2016, filed 1 Feb 2017.